| Adam Carr, | |
|
410 N Willowbrook Rd, Coldwater, MI 49036-9462 | |
| (517) 278-8727 | |
| Not Available |
| Full Name | Adam Carr |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 410 N Willowbrook Rd, Coldwater, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760977169 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 5101025846 (Michigan) | Primary |
| Entity Name | Hillsdale Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730115940 PECOS PAC ID: 7214846260 Enrollment ID: O20040805000518 |
News Archive
...and to protect them from human rights violations, such as human trafficking, according to this year's State of the World Population report released Wednesday by the United Nations Population Fund, New Era/AllAfrica.com reports.
Cell biologists pondering the death of neurons - brain cells - said today that by eliminating one ingredient from the cellular machinery, they prolonged the life of neurons stressed by a pesticide chemical. The finding identifies a potential therapeutic target to slow changes that lead to neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.
The Obama administration has set aside $19B for physicians to adopt electronic medical record systems. Today, 75% of doctors practice in offices with 10 doctors or fewer. For them, the investment is cost-prohibitive: the technology costs from $25,000 to over $75,000. Not surprisingly, only 17% of physicians use computerized records, according to the New York Journal of Medicine. Yet, one service provider allows physicians to switch to electronic medical records - free - and make their practice more profitable.
Novartis today presented results from a pivotal Phase III clinical trial exploratory subgroup analysis showing a 7.8-month improvement in median progression-free survival when using Farydak in combination with bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who had received two or more prior regimens, including bortezomib and an immunomodulatory agent.
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
› Verified 3 days ago
| Entity Name | Family Practice & Orthopedic Care Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861720831 PECOS PAC ID: 8820123730 Enrollment ID: O20100317000838 |
News Archive
...and to protect them from human rights violations, such as human trafficking, according to this year's State of the World Population report released Wednesday by the United Nations Population Fund, New Era/AllAfrica.com reports.
Cell biologists pondering the death of neurons - brain cells - said today that by eliminating one ingredient from the cellular machinery, they prolonged the life of neurons stressed by a pesticide chemical. The finding identifies a potential therapeutic target to slow changes that lead to neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.
The Obama administration has set aside $19B for physicians to adopt electronic medical record systems. Today, 75% of doctors practice in offices with 10 doctors or fewer. For them, the investment is cost-prohibitive: the technology costs from $25,000 to over $75,000. Not surprisingly, only 17% of physicians use computerized records, according to the New York Journal of Medicine. Yet, one service provider allows physicians to switch to electronic medical records - free - and make their practice more profitable.
Novartis today presented results from a pivotal Phase III clinical trial exploratory subgroup analysis showing a 7.8-month improvement in median progression-free survival when using Farydak in combination with bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who had received two or more prior regimens, including bortezomib and an immunomodulatory agent.
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Carr, 401 W Greenlawn Ave, Lansing, MI 48910-2819 Ph: (517) 975-6000 | Adam Carr, 410 N Willowbrook Rd, Coldwater, MI 49036-9462 Ph: (517) 278-8727 |
News Archive
...and to protect them from human rights violations, such as human trafficking, according to this year's State of the World Population report released Wednesday by the United Nations Population Fund, New Era/AllAfrica.com reports.
Cell biologists pondering the death of neurons - brain cells - said today that by eliminating one ingredient from the cellular machinery, they prolonged the life of neurons stressed by a pesticide chemical. The finding identifies a potential therapeutic target to slow changes that lead to neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.
The Obama administration has set aside $19B for physicians to adopt electronic medical record systems. Today, 75% of doctors practice in offices with 10 doctors or fewer. For them, the investment is cost-prohibitive: the technology costs from $25,000 to over $75,000. Not surprisingly, only 17% of physicians use computerized records, according to the New York Journal of Medicine. Yet, one service provider allows physicians to switch to electronic medical records - free - and make their practice more profitable.
Novartis today presented results from a pivotal Phase III clinical trial exploratory subgroup analysis showing a 7.8-month improvement in median progression-free survival when using Farydak in combination with bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who had received two or more prior regimens, including bortezomib and an immunomodulatory agent.
Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and develop monoclonal antibody drugs. Apexigen will generate and screen antibodies to several targets specified by Centocor R&D, which will be responsible for development and commercialization of all products resulting from the collaboration.
› Verified 3 days ago
Mark D Mayer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 320 E Chicago St, Coldwater, MI 49036 Phone: 517-279-5050 Fax: 517-279-5051 | |
Frank Laurence Bunch Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 410 N Willowbrook Rd, Coldwater, MI 49036 Phone: 517-279-9599 Fax: 517-279-1679 | |
Dr. Anand Mukund Manohar, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 87 W Pearl St, Coldwater, MI 49036 Phone: 517-278-7122 Fax: 517-279-4974 | |
Richard John Hartman Jr., DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 N Willowbrook Rd, Coldwater, MI 49036 Phone: 517-279-9599 Fax: 517-279-1679 |